• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOFIRE DIAGNOSTICS, LLC BIOFIRE® BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOFIRE DIAGNOSTICS, LLC BIOFIRE® BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL Back to Search Results
Model Number RFIT-ASY-0147
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/18/2024
Event Type  malfunction  
Event Description
Summary: (b)(6) reported two potential false positive serratia marcescens results on the biofire blood culture identification 2 (bcid2) panel for the same patient after testing the patient's blood culture sample.Due to the biofire bcid2 panel result, the patient was not affected.The investigation determined that the most likely cause of the discrepant s.Marcescens result was the presence of non-viable organism/nucleic acid in the blood culture media bottle.
 
Manufacturer Narrative
Investigation: two potential false positive serratia marcescens results on the biofire bcid2 panel for the same patient was reported after testing the patient's blood culture sample.Both tests were performed on february 18, 2024.The patient was not affected due to the biofire bcid2 result.The same sample was used for all additional testing.Gram-stain showed gram positive cocci in pairs and clusters.Customer reports culture was done but no results were reported.No serious injury or death reported.Conclusion: the investigation determined that the most likely cause of the discrepant s.Marcescens result was the presence of non-viable organism/nucleic acid in the blood culture media bottle.While blood culture vials are autoclaved and routinely quality controlled for sterility, non-viable organisms or nucleic acids can remain in the blood culture media after the sterilization process.The presence of non-viable organisms and nucleic acid does not compromise the intended use of blood culture media, culturing viable microorganisms; however, the biofire bcid2 panel does not distinguish between nucleic acid from viable or non-viable organisms.The biofire bcid2 panel is working as intended.The "laboratory precaution" and "limitation" sections of the biofire bcid2 panel instructions for use (ifu) (www.Online-ifu.Com/iti0048) outlines the potential for false positive detections during molecular testing with sterile blood culture media containing detectable levels of non-viable organisms and/or nucleic acid.Importantly, results from the biofire bcid2 panel are intended to be correlated with the clinical history, epidemiological data, and other data available to the clinician evaluating the patient.All identification results provided by the biofire bcid2 panel are intended to be interpreted in conjunction with gram stain results.Clinical performance: according to table 33.Biofire bcid2 panel clinical performance summary, enterobacterales of the biofire bcid2 panel ifu, the performance claim for the s.Marcescens assay compared to standard manual and automated microbiological/biochemical identification methods showed an overall sensitivity of 100% (95% ci 87.5-100%) and an overall specificity of 100% (95% ci 99.7-100%).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOFIRE® BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL
Type of Device
BIOFIRE® BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL
Manufacturer (Section D)
BIOFIRE DIAGNOSTICS, LLC
515 colorow dr
salt lake city UT 84108
Manufacturer (Section G)
BIOFIRE DIAGNOSTICS, LLC
515 colorow dr
salt lake city UT 84108
Manufacturer Contact
515 colorow dr
salt lake city, UT 84108
8017366354
MDR Report Key18943098
MDR Text Key339219916
Report Number3002773840-2024-00283
Device Sequence Number1
Product Code PAM
UDI-Device Identifier00815381020338
UDI-Public00815381020338
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193519
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberRFIT-ASY-0147
Device Catalogue NumberRFIT-ASY-0147
Device Lot Number2561023
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/21/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/30/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age86 YR
Patient SexMale
-
-